FDA NDC Directory · JSON-LD · Markdown

cisatracurium besylate

NDC 0781-3152 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA200159
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCISATRACURIUM BESYLATE (2 mg/mL)
Marketing started20120716
Package count1

External sources

Source: openFDA. Public-domain (CC0).